These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32530988)

  • 21. Nonalcoholic fatty liver disease increases the risk of gastroesophageal reflux disease: A systematic review and meta-analysis.
    Xue J; Xin H; Ren N; Zhou C; Yang J; Song L; Qin S
    Eur J Clin Invest; 2019 Sep; 49(9):e13158. PubMed ID: 31338830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies.
    Jarvis H; Craig D; Barker R; Spiers G; Stow D; Anstee QM; Hanratty B
    PLoS Med; 2020 Apr; 17(4):e1003100. PubMed ID: 32353039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis.
    Rich NE; Oji S; Mufti AR; Browning JD; Parikh ND; Odewole M; Mayo H; Singal AG
    Clin Gastroenterol Hepatol; 2018 Feb; 16(2):198-210.e2. PubMed ID: 28970148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significant Association Between Gallstone Disease and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Jaruvongvanich V; Sanguankeo A; Upala S
    Dig Dis Sci; 2016 Aug; 61(8):2389-2396. PubMed ID: 26993825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The utility of NAFLD fibrosis score for prediction of mortality among patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of cohort study.
    Jaruvongvanich V; Wijarnpreecha K; Ungprasert P
    Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):629-634. PubMed ID: 28716600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Periodontitis and Non-alcoholic Fatty Liver Disease, a population-based cohort investigation in the Study of Health in Pomerania.
    Akinkugbe AA; Slade GD; Barritt AS; Cole SR; Offenbacher S; Petersmann A; Kocher T; Lerch MM; Mayerle J; Völzke H; Heiss G; Holtfreter B
    J Clin Periodontol; 2017 Nov; 44(11):1077-1087. PubMed ID: 28804947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonalcoholic fatty liver disease is associated with coronary artery calcification: A systematic review and meta-analysis.
    Jaruvongvanich V; Wirunsawanya K; Sanguankeo A; Upala S
    Dig Liver Dis; 2016 Dec; 48(12):1410-1417. PubMed ID: 27697419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of sugar sweetened beverages consumption with non-alcoholic fatty liver disease: a systematic review and meta-analysis.
    Asgari-Taee F; Zerafati-Shoae N; Dehghani M; Sadeghi M; Baradaran HR; Jazayeri S
    Eur J Nutr; 2019 Aug; 58(5):1759-1769. PubMed ID: 29761318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations of sugar- and artificially sweetened soda with nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Wijarnpreecha K; Thongprayoon C; Edmonds PJ; Cheungpasitporn W
    QJM; 2016 Jul; 109(7):461-466. PubMed ID: 26385233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helicobacter pylori and Risk of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
    Wijarnpreecha K; Thongprayoon C; Panjawatanan P; Manatsathit W; Jaruvongvanich V; Ungprasert P
    J Clin Gastroenterol; 2018; 52(5):386-391. PubMed ID: 28098578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Taylor RS; Taylor RJ; Bayliss S; Hagström H; Nasr P; Schattenberg JM; Ishigami M; Toyoda H; Wai-Sun Wong V; Peleg N; Shlomai A; Sebastiani G; Seko Y; Bhala N; Younossi ZM; Anstee QM; McPherson S; Newsome PN
    Gastroenterology; 2020 May; 158(6):1611-1625.e12. PubMed ID: 32027911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Mantovani A; Nascimbeni F; Lonardo A; Zoppini G; Bonora E; Mantzoros CS; Targher G
    Thyroid; 2018 Oct; 28(10):1270-1284. PubMed ID: 30084737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promotional effect of nonalcoholic fatty liver disease on Gallstone disease: A systematic review and meta-analysis.
    Shen SS; Gong JJ; Wang XW; Chen L; Qin S; Huang LF; Chen YQ; Ren H; Yang QB; Hu HD
    Turk J Gastroenterol; 2017 Jan; 28(1):31-39. PubMed ID: 27991855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis.
    Mantovani A; Dauriz M; Byrne CD; Lonardo A; Zoppini G; Bonora E; Targher G
    Metabolism; 2018 Oct; 87():1-12. PubMed ID: 29935236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis.
    Candia R; Ruiz A; Torres-Robles R; Chávez-Tapia N; Méndez-Sánchez N; Arrese M
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):656-62. PubMed ID: 25418531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of PNPLA3 rs738409 G/C gene polymorphism with nonalcoholic fatty liver disease in children: a meta-analysis.
    Tang S; Zhang J; Mei TT; Guo HQ; Wei XH; Zhang WY; Liu YL; Liang S; Fan ZP; Ma LX; Lin W; Liu YR; Qiu LX; Yu HB
    BMC Med Genet; 2020 Aug; 21(1):163. PubMed ID: 32811452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperuricemia is associated with nonalcoholic fatty liver disease activity score in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Jaruvongvanich V; Ahuja W; Wirunsawanya K; Wijarnpreecha K; Ungprasert P
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1031-1035. PubMed ID: 28639970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased arterial stiffness in nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Jaruvongvanich V; Chenbhanich J; Sanguankeo A; Rattanawong P; Wijarnpreecha K; Upala S
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):e28-e35. PubMed ID: 28542113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association Between Nonalcoholic Fatty Liver Disease and Reduced Bone Mineral Density in Children: A Meta-Analysis.
    Mantovani A; Gatti D; Zoppini G; Lippi G; Bonora E; Byrne CD; Nobili V; Targher G
    Hepatology; 2019 Sep; 70(3):812-823. PubMed ID: 30706504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.
    Ballestri S; Zona S; Targher G; Romagnoli D; Baldelli E; Nascimbeni F; Roverato A; Guaraldi G; Lonardo A
    J Gastroenterol Hepatol; 2016 May; 31(5):936-44. PubMed ID: 26667191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.